OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
September 11, 2020
The FDA issued a safety alert about efficacy and potential safety concerns with a combination therapy being studied for the treatment of breast cancer.
September 10, 2020
Oncology pharmacists have implemented new ways to communicate with patients, schedule visits and treatments, and re-evaluate their medications regimens during the pandemic.
September 03, 2020
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to a major new study.
Oral azacitidine (Onureg; Celgene) is approved for patients in first remission with acute myeloid leukeimia.
August 19, 2020
Oncology medical and infusion services have declined since the start of COVID-19.
August 13, 2020
Results from the study showed antitumor activity and safety to be similar to olaparib and durvalumab monotherapy study findings.
August 12, 2020
Pharmacists should counsel patients on how taking steps now can prevent certain cancers later.
August 07, 2020
The advent of generic and biosimilar medicines for novel treatments has helped bridge the gap in the delivery of cancer care between the United States and India, according to the study.
August 06, 2020
ESMO released changes to its recommendations on how to manage patients with cancer during the COVID-19 pandemic.
August 03, 2020
A recent study evaluated the effects of the COVID-19 pandemic on normal cancer care activities, including cancer screening efforts.